Bioceres Crop Solutions | BIOX | Long at $1.43

Technical Analysis

• Bioceres Crop Solutions BIOX has entered my selected "crash" simple moving average. This area is often a zone of share accumulation and may result in a trend reversal (or a short-term stair-step down to $1 or lower before trading sideways).
  

Growth, Fundamentals, & Health

• Not expected to become profitable again until 2028.
  
• Earnings-per-shares growth from 2026 (-$0.26) to 2028 ($0.56): +323%
  
• Revenue growth from 2026 ($350 million) to 2028 ($511 million): +46%
  
• Current Fair Value: $5
  
• Debt-to-Equity: 0.9x (very good / healthy)
  
• Altman's Z-Score/Bankruptcy Risk: .9 (high risk, some financial distress)
  

Action

• 75% technical analysis play and only 25% based on company fundamentals. The only major risk based on the data is bankruptcy. The near-term could be rough for the company, but the outlook into 2028 shows significant growth. Thus, at $1.43, BIOX is in a personal buy zone. There could be near-term risk near $1 or a bit lower, but this one is a total gamble. Time will tell.
  

Targets into 2028

1. $2.00 (+39.9%)
   
2. $4.00 (+179.7%)